CDFI

SKU: orb1942009

Description

CDFI is a small molecule inhibitor of the lipid II flippase MurJ, thereby blocking cell wall biosynthesis in methicillin-resistant Staphylococcus aureus (MRSA). It is utilized in research to study bacterial peptidoglycan assembly and to investigate novel antimicrobial strategies in both in vitro and in vivo models of MRSA infection.

Key Properties

• CAS Number: 1199797-92-6
• MW: 446.99
• Purity: 99.86% (May vary between batches)
• Formula: C₂₈H₂₈ClFN₂
• SMILES: FC=1C=CC=2NC(C=3C=CC=CC3Cl)=C(C2C1)C4CCN(CC=5C=CC=C(C5C)C)CC4
• Target: Others
• Solubility: DMSO:80 mg/mL (178.97 mM);10% DMSO+40% PEG300+5% Tween 80+45% Saline:3.3 mg/mL (7.38 mM)

Bioactivity

• In Vitro:
  CDFI is a novel anti-infective agent targeting MRSA cell wall biosynthesis.

Storage & Handling

• Storage: -20°C
• Expiration Date: 12 months from date of receipt.
• Disclaimer: For research use only

Compound Identifiers

PubChem CID

91222279